Neuroendocrine gene expression in the hypothalamus: in situ hybridization histochemical studies.
1. We have reviewed recent studies in which in situ hybridization histochemistry (ISHH) was used to investigate the regulation of expression of neurohypophysial peptides and hypothalamic releasing hormones. 2. ISHH is a technique in which the presence and quantity of a specific mRNA can be determined in tissue sections with a high degree of resolution and sensitivity. 3. ISHH has been used to measure changes in cellular levels of mRNAs encoding vasopressin, oxytocin, corticotropin-releasing factor, gonadotropin-releasing hormone, thyrotropin-releasing hormone and somatostatin in response to various physiological challenges. 4. A theme emerging from these studies is that changes in levels of mRNA encoding neuroendocrine peptides reflect changes in biosynthesis and secretion.
D000818:Animals; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism / Q000502:physiology; D005260:Female; D005786:Gene Expression Regulation; D006651:Histocytochemistry; D007031:Hypothalamus / Q000378:metabolism* / Q000502:physiology; D008297:Male; D009693:Nucleic Acid Hybridization; D010906:Pituitary Hormone-Releasing Hormones / Q000378:metabolism* / Q000502:physiology; D010909:Pituitary Hormones, Posterior / Q000378:metabolism* / Q000502:physiology; D012333:RNA, Messenger / Q000032:analysis*; D051381:Rats; D011910:Rats, Brattleboro; D013004:Somatostatin / Q000378:metabolism* / Q000502:physiology; D013973:Thyrotropin-Releasing Hormone / Q000378:metabolism / Q000502:physiology
D010906:Pituitary Hormone-Releasing Hormones; D010909:Pituitary Hormones, Posterior; D012333:RNA, Messenger; D013004:Somatostatin; D013973:Thyrotropin-Releasing Hormone; D003346:Corticotropin-Releasing Hormone